Computer-Based Therapy for Mild Cognitive Impairment

This study has been completed.
Sponsor:
Collaborators:
University of California, San Francisco
University of California, Davis
Stanford University
Information provided by:
Posit Science Corporation
ClinicalTrials.gov Identifier:
NCT00319943
First received: April 27, 2006
Last updated: NA
Last verified: April 2006
History: No changes posted

April 27, 2006
April 27, 2006
September 2004
Not Provided
  • The study investigates changes in a neuropsychological assessment battery pre-randomization
  • and upon the completion of training.
Same as current
No Changes Posted
  • Early evaluations will be conducted from brain imaging; specifically, date
  • obtained via positron emission tomography (PET), magnetoencephalography (MEG),
  • electroencephalography (EEG), and functional magnetic resonance imaging (fMRI)
  • studies.
Same as current
Not Provided
Not Provided
 
Computer-Based Therapy for Mild Cognitive Impairment
Computer-Based Therapy for Mild Cognitive Impairment

The purpose of this study is to determine the neuropsychological and neurophysiological impacts of a computer-based training program designed to improve the cognitive performance of patients with mild cognitive impairment (MCI).

The study is a randomized, double-blind, controlled trial of a computerized, cognitive intervention with three main goals: 1) to assess the magnitude of improvements in memory, language function, and cognitive function following computer training, 2) to investigate the neurophysiological mechanisms underlying such neuropsychological improvements, and 3) to demonstrate the feasibility of using this kind of computer-based therapy in older populations.

Interventional
Phase 1
Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double-Blind
Primary Purpose: Treatment
Mild Cognitive Impairment
Procedure: Computer-based training for Mild Cognitive Impairment (MCI)
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
48
July 2006
Not Provided

Inclusion Criteria:

1)65 - 90 years of age 2)Meet definition for MCI including complaints of cognitive decline as indicated by patient report and/or informant report, and corroborated by clinician judgment and, the absence of dementia, defined as impairment of memory and at least one other domain of cognitive function.

3)Fluency in English 4)Willing to meet the time commitment of the study

-

Exclusion Criteria:

  1. Clinically significant cerebrovascular disease
  2. Individuals scheduled to begin acetylcholinesterase inhibitor (AChEI) therapy -
Both
65 Years to 90 Years
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00319943
OUT-108-2005
Not Provided
Not Provided
Posit Science Corporation
  • University of California, San Francisco
  • University of California, Davis
  • Stanford University
Principal Investigator: Joel Kramer, PsyD University of California, San Francisco
Posit Science Corporation
April 2006

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP